Books
Kaplan A, Opheim KE, Jack R, Toivola B, Lyon AW. 1995. Clinical Chemistry: Interpretation and Techniques. 4th Edition. Philadelphia, Lea and Febiger, 475

Lyon AW. 1988. Characterization of the inhibition of hepatic protein synthesis during acute ethionine intoxication of the rat. Doctoral Thesis. Queen's University, Kingston, Ontario

Book - Chapters
Lyon AW, Lyon ME.  Flame Atomic Emission Spectrometry and Atomic Absorption Spectrometry.  Encyclopedia of Medical Devices and Instrumentation 2nd Ed.  Editor J.G. Webster. J.W. Wiley & Sons, Inc. Hoboken, NJ. 2006  pp. 315-322.

Papers

1. Khan FM, Ueno-Yamanouchi A, Serushago B, Bowen T, Lyon AW, Lu C, Storek J. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Asthma Clin Immunol. 2012 Jan 20;8(1):1
2. Fenton TR, Lyon AW. Milk and Acid-Base Balance: Proposed Hypothesis versus Scientific Evidence. J Am Coll Nutr 2011; 30(5): 471S-475S.
3. Straseski JA, Lyon ME, Clarke W, Dubois JA, Phelan LA, Lyon AW. Investigating Interferences of a Whole-Blood Point-of-Care Creatinine Analyzer: Comparison to Plasma Enzymatic and Definitive Creatinine Methods in an Acute-Care Setting. Clin Chem.2011; 57: 1566-73. Podcast Interview Link and Interview Transcript.
4. Fenton TR, Lyon AW, Rose MS. Calcium, phosphate, magnesium and alkaline phosphatase gestational age-specific reference intervals for preterm infants. BMC Pediatrics 2011, 11:76.
5. Pollak PT, Verjee Z, Lyon AW. Risperidone-induced QT prolongation following overdose correlates with serum drug concentration and  resolves rapidly with no evidence of altered pharmacokinetics. J Clin Pharmacol 2011; 51: 1112-5.
6. Fenton TR, Tough SC, Lyon AW, Eliasziw M, and Hanley DA. Causal assessment of dietary acid load and bone disease: A systematic review and meta-analysis applying Hill's epidemiologic criteria for causality. Nutrition Journal 2011, 10:41
7. Lyon ME, Lyon AW. Patient acuity exacerbates discrepancy between whole blood and plasma
   methods through bias and variance in molality to molarity conversion: “Mind the gap!” - Clin Biochem 2011; 44:412-417.
8. Lyon ME, Lyon AW. Analysis of the Performance of the CONTOUR-TS Blood Glucose Monitoring System:  When regulatory performance criteria are met, should we have confidence to use a medical device with all patients? Journal of Diabetes Science and Technology 2011; 5(1):1788-1790.
9. Gracie SK, Lyon AW, Kehler HL, Pennell CE, Dolan SM, McNeil DA, Siever JE, McDonald SW, Bocking AD, Lye SJ, Hegadoren KM, Olson DM, Tough SC. All Our Babies Study: Community-based cohorts to assess the association of pregnancy experience and birth outcomes, including preterm birth, in Alberta, Canada. BMC Pregnancy and Childbirth 2010, 10:87.
10. ME Lyon, JA DuBois,GH Fick, AW Lyon. Estimates of analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose and ascorbate. J. Diabet Sci Technol, 2010; 4(6):1479-1494.
    
11. Fenton TR, Eliasziw M, Lyon AW,Tough SC, Brown JP and Hanley DA. Low urine pH and acid excretion do not predict bone fractures or the loss of bone mineral density: a prospective cohort study. BMC Musculoskeletal Disorders 2010, 11:88.
12. Csorba TR, Lyon AW, Hollenberg MD. Autoimmunity and the pathogenesis of type 1 diabetes. Crit Rev Clin Lab Sci. 2010; 47: 51-71.
13. M. E. Lyon, D. Gray, L.B. Baskin, J.A. Dubois, AW. Lyon. A mathematical model to assess the influence of hematocrit on point of care glucose meter performance. Clin Biochem. 2010; 43: 905-9.
14. Lyon AW, James J, Lemaire C, Culleton B. Comparison of the multiple-aliquot and batch methods of monitoring peritoneal dialysis adequacy in patients. Perit Dial Int. 2010; 30: 91-4.
15. Fenton TR, Lyon AW, Eliasziw M, Tough SC, Hanley DA. Phosphate decreases urine calcium and increases calcium balance: A meta-analysis of the osteoporosis acid-ash diet hypothesis. Nutrition J: 2009; 8:41.
16. Fenton TR, Eliasziw M, Lyon AW, Tough SC, Brown JP, Hanley DA. Low 5-year stability of within-patient ion excretion and urine pH in fasting-morning-urine specimens. Nutr Res. 2009; 29(5): 320-6.
17. Higgins T, Saw W, Sikaris K, Cembrowski GC, Lyon AW, Khajuria A, Tran D. Seasonal variation in hemoglobin A1c: Is it the same in both hemispheres? J. Diabetes Sci Technol 2009; 3(4):668-671.
    
18. Fenton, TR, Lyon AW, Eliasziw M, Tough SC, Hanley DA. A meta-analysis of the effect of the acid-ash hypothesis of osteoporosis on calcium balance. J Bone Min Res. 2009; 24:1835-40.
    
19. Lyon AW, Higgins TN, Wesenberg JC, Tran DV. Variation in the frequency of HbA1c testing: Population-studies to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes. J Diabetes Sci Technol 2009; 3: 411-417.
    
20. Tran DV, Lyon AW, Higgins TN, Wesenberg JC, Vandergouwe L, Cembrowski GS. Use of serial patient differences of immunoassay and HPLC HbA1c to determine long term instrument performance. J Diabetes Sci Technol 2009; 3: 424-428.
    
21. Hicks M, Tough SC, Premji S, Benzies K, Lyon AW, Mitchell I, Sauve R. Alcohol and drug screening of newborns: Would women consent? J Obs Gyn Can 2009; 31: 331-339.
    
22. Kline G, Weeks S, Lyon A, Jamieson P, Kline RL. A case of acquired salt-wasting orthostasis due to a syndrome of inappropriate cardiac natriuretic peptides secretion. Clin Chim Acta 2009; 401:184-6.
23. James MT, Zhang J, Lyon AW, Hemmelgarn BR. Reduction in misclassification of calcium status through application of a local equation for albumin adjusted calcium. BMC Clinical Pathology 2008, 8:12.
24. Fenton TR, Tanis R Fenton, Michael Eliasziw, Andrew W Lyon, Suzanne C Tough, David A Hanley. A meta-analysis of quantity of calcium excretion associated with the net acid excretion of the modern diet under the acid-ash diet hypothesis Am J. Clin Nutri 2008 88:1159-66
25. Manley SA, Byrns S, Lyon AW, Brown P, Gailer J. Simultaneous Cu, Fe and Zn-specific detection of plamsa metalloproteins by size exclusion chromatography-inductively coupled plasma atomic emission spectroscopy. J Biol Inorg Chem. 2009; 14(1): 159.
26. Hansson P, Lyon A. Hur kan man leva utan albumin? Nagra fall av analbuminemi vacker patofysiologiska fragor How is it possible to live without albumin? Several recent cases of analbuminemia raise physiopathological questions. Lakartidningen 2008; 105(23): 1768-70.
27. Csorba TR, Lyon AW. Abnormal proinsulin congeners as autoantigens that initiate the pathogenesis of Type I diabetes. Medical Hypotheses 2005; 64:186-191.
28. Lyon AW, Larsen ET, Edwards AL. The impact of new guidelines for glucose tolerance testing on clinical practice and laboratory services.CMAJ. 2004 Oct 26;171(9):1067-9.
29. Lyon ME, Ball CL, Krause RD, Slotsve GA, Lyon AW. Effect of hemolysis on cardiac Troponin T determination by the Elecsys. 2010 Immunoanalyzer Clin Biochem 2004; 37(8): 698-701.
30. Newstead J, Card S, Lyon AW. Low serum albumin and abnormal body shape in a young Canadian First Nations woman. Lab Med. 2004; 35(6): 350-356.
31. Lyon AW, Whitley C, Eintracht SL. Analytical evaluation and application of a novel spectrophotometric serum lithium method to a rapid response laboratory. Ther Drug Monit. 2004; 26: 98-101.
32. Hicks M, Sauve RS, Lyon AW, Clarke M, Tough S. Alcohol use and abuse in pregnancy: An evaluation of the merits of screening. Can Child Adol Psych Rev 2003; 12: 77-80.
33. Campagnoli M, Kragh-Hansen U, Overgaard Pedersen A, Amoresano A, Lyon AW, Cesati R, Sala A, Romano A, Galliano M, and Minchiotti L. Structural analysis, fatty acid and thyroxine binding properties of Vancouver and Naskapi variants of human serum albumin. Clin Biochem 2003; 36: 597-605.
34. Lyon ME, Ball CL, Lyon AW, Walpole E, Church DL. A preliminary evaluation of the interaction between urine specific gravity and leukocyte esterase results using Bayer Multistix and the Clinitek 500. Clin Biochem 2003; 35: 579-81.
35. Lyon AW, Baskin LB. Pseudohyponatremia in a Myeloma Patient: Direct Electrode Potentiometry is a Method Worth its Salt. Lab Med. 2003. 34(5): 357-60.
36. Lyon AW, Mayhew WJ. Cesium toxicity: a case of self-treatment by alternate therapy gone awry. Ther Drug Monit. 2003 Feb;25(1):114-6.
37. Zhang Z, Juurlink BHJ, Lyon AW, Paterson PG. Effects of dietary protein and L-2-oxothiazolidine-4-carboxylate on rat brain glutathione concentration. Nutrition Research 2002, 22: 1475-86.
38. Lyon AW, Mansoor A, Trotter MJ. Urinary Gems, Acyclovir Crystalluria , Arch Path Lab Med 2002; 126: 753-4.
39. Galliano M, Campagnoli M, Rossi A, Wirsing von Konig CH, Lyon AW, Cefle K, Yildiz A, Palanduz S, Ozturk S, Minchiotti L. Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families. Clin Chem. 2002 ;48:844-9.
40. Paterson PG, Juurlink BHJ, Lyon AW, Kamencic H, Andersen LB. Sulfur amino acid deficiency depresses brain glutathione concentration. Nutr Neurosci. 2001; 4(3):213-22.
41. Katrusiak A.E, Paterson P.G, Kamencic H, Shoker A, Lyon A.W. A UV-HPLC method for determination of total and reduced cysteine, cystinylglycine, homocystine and glutathione in plasma and cells extracts. J Chromatography B. Biomed Sci Appl (2001) 758: 207-212.
42. Kamencic H, Griebel RW, Lyon AW, Paterson PG, BHJ Juurlink (2001), Promoting glutathione synthesis following spinal cord trauma decreases secondary damage and promotes retention of function. FASEB Journal 15: 243-250.
43. Kamencic H, Lyon A, Paterson P.G., Juurlink BHJ. 2000 Monochlorobimane fluorometric method to measure tissue glutathione Anal Biochem 286:35-7.
44. Lyon ME, Rutledge Harding S, Oosman SN, Lyon AW. 2000 Evaluation of Argatroban and DuP714 as anticoagulants for blood gas, electrolyte and ionized calcium analyses. Scand. J. Clin. Labs. Invest. 60: 19-26.
45. Lyon ME, Drobot DW, Harding SR, Lyon AW.  Evaluation of the thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with the factor Xa inhibitor 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK)
    as anticoagulants for critical care clinical chemistry specimens.  Clin Chim Acta 1999;280(1-2):91-9.
46. Lyon AW, Meinert P, Bruce GA, Laxdal VA, Salkie ML. Influence of methodology on the detection and diagnosis of congenital analbuminemia. Clin. Chem. 1998; 44: 2365-7.
47. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. 1997 "Use of thrombin inhibitors ex vivo allows critical care clinical chemistry and hematology testing in common specimens" Clin Biochem 30:121-128.
48. Hindmarsh JT, Lyon AW. 1996. Strategies to improve the utilization of clinical chemistry services. Clinical Biochemistry 29:291-300
49. Lyon ME, Fine JS, Henderson, PJ, Lyon AW. 1995. D-phenylalanyl-L-prolyl-Larginine chloromethylketone
    (PPACK) is an alternative anticoagulant to heparin salts for blood gas, electrolyte and ionized calcium specimens. Clinical Chemistry 41:1038-41
50. Lyon AW, Duran G, Raisys VA. 1995. "Determination of thalidomide by high performance liquid chromatography: methodological strategy for clinical trials". Clinical Biochemistry 28: 467-470
51. Lyon AW, Greenway DC, Hindmarsh JT. 1995. "A strategy to promote rational clinical chemistry test utilization". American Journal Clinical Pathology 103: 718-724
52. Lyon AW, Schaan B, Laxdal VA, Massey KLM. 1995. Evaluation of an Immunoturbidimetric Assay for Hemoglobin Alc. Clinical Biochemistry 28(1): 97-100
53. Lyon AW, Anastassiades T, Kisilevsky R. 1993. In vivo analysis of murine serum sulphate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis. Journal of Rheumatology 20:1108-1113
54. Kisilevsky R, Lyon AW, Young ID. 1992. A critical analysis of postulated pathogenic mechanisms in amyloidosis. Critical Reviews in Laboratory Medicine 29:59-82
55. Dow KE, Riopelle RJ, Szarek WA, Bols M, Ison ER, Plenkiewicz J, Lyon A, Kisilevsky R. 1992. Effects of 4-deoxy-L-threo-pentose, a novel carbohydrate on neural cell proteoglycan synthesis and function. Biochimica et Biophysica Acta 1156:7-14
56. Lyon AW, Narindrasorasak S, Anastassiades T, Couchman JR, McCarthy K, Kisilevsky R. 1991. Co-deposition of basement membrane components during the induction of murine splenic AA amyloid. Laboratory Investigation 64:785-790
57. Lyon AW, Kisilevsky R. 1990. Inhibition of the initiation of hepatic protein synthesis during ethionine mediated ATP depletion in vivo: Modification to ribosomal subunits, evidence of impaired ternary complex formation and a subcellular redistribution of eIF-2 alpha. Biochimica Biophysica Acta 1049:158-170
58. Lyon AW, Kisilevsky R. 1986. Changes in glucose metabolism following the administration of ethionine: Its role in regulating hepatic protein synthesis. Toxicological Pathology 14:424-428
    

Lyon AW. Comment on Interview on Dr. Wilt and PSA Screening. As It Happens, Canadian Broadcasting Corporation, Oct. 10, 2011. Part 2, 12:38 -13:35.

Lyon AW. Improving the Use of Lab Resources: How CLS reduced the volume of folic acid testing in Calgary. CLS Lab Link Newsletter. June 2011 (Issue 2).

Lyon AW. Could elevated potassium results be due to dehydration?[Letter] MLO Tips from Clinical Experts Medical Laboratory Observer 2011, 43(7): 34-35.

MacDonald AM, Kinniburgh D, Lyon AW. A Novel Designer Drug—Bromo-Dragonfly. Therapeutics & Toxins News, AACC TDM & CT Division, Summer 2011.

Storek J, Vliagoftis H, Grizel A, Lyon A, Daly A, Khan F, Bowen T, Game M, Larratt L, Turner R, Huebsch L. Allergy transfer with hematopoietic cell transplantation from an unrelated donor.[Letter to the Editor] Bone Marrow Transplantation, 2011; 46: 605–606.

LeHotay D, Lyon AW. Clinical and Scientific Leaders Converge on Saskatoon for CSCC. CSCC News Apr 2010, p4-5.

Fenton TR, Eliasziw M, Lyon AW, Tough SC, and Hanley DA. Reply to HM Macdonald et al [Letter to the Editor] Am. J. Clinical Nutrition, Mar 2009; 89: 927

Lyon AW.  Acute coronary syndromes. [Letter to the Editor] Lancet. 1999; 354(9181):867.

Lyon AW, Raisys VA. Handling of blood samples for determination of thalidomide. [Letter to the Editor, reply] Clin Chem 1997; 43:1095-6

Lyon AW. 1995. Cost analysis of POC testing. [Letter to the Editor]. American Journal of Clinical Pathology. 104: 107-108.

Lyon AW. 1995. Education in Clinical Chemistry & Internet and the Clinical Biochemist Canadian Society of Clinical Chemists Newsletter, 37(2) : 5-6.

Lyon AW. 1995. MedChem Travelling Lecturer 1994: Dr. H.K.Naito. Canadian Society of Clinical Chemists Newsletter, 36(6):4.

Lyon AW. 1995. Highlights: The Academic Board. Canadian Society of Clinical Chemists Newsletter, 36(4):4.

Invited papers in published conference proceedings

Ooi DS, Lyon AW, Ooi TC. 1991. Relationship of rate nephelometric-analysed serum apolipoprotein A1 and B with cholesterol utilized as a means of quality control. 5th Asian-Pacific Congress of Clinical Biochemistry, Kobe, Japan, 29 September-4 October. Progress in Clinical Biochemistry 73-75

Lyon AW, Narindrasorasak S, McCarthy K, Couchman JR, Kisilevsky R. 1990. Basement membrane components in addition to HSPG are present in murine AA amyloid deposits. VIth International Symposium on Amyloidosis, Oslo, Norway, 5-8 August. Proceedings of the VIth International Symposium on Amyloidosis,
Pergamon Press, New York, NY

Abstracts and Poster Presentations

1. Metcalfe A, Lyon A, Johnson J, Bernier F, Currie G, Lix L, Tough S.Linkage of Clinical and Administrative Data to
   Identify a Conception Cohort. WHO-Family of International Classifications -Annual Meeting, Cape Town, South Africa, Oct 29, 2011.
2. Lyon ME, Dubois J, Slingerland RJ, Dikkeschei LD, Lyon AW. Theoretical Impact of Detecting Whole Blood Glucose Molality and Reporting Plasma Glucose Molarity in Various Patient Populations. 2011 International Hospital Diabetes Meeting, Nov 17 – 19, 2011. Barcelona, Spain.
3. MacDonald AM, Zhang X, Kinniburgh DW, Lyon AW. Reduction of Oxazepam to Nordiazepam and Temazepam to Diazepam in the Urine of Drug Rehabilitation Program Patients 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, October, 2011. Stuttgart, Germany.
4. Chin AC, Lyon ME, Slotsve GA, Lyon AW. Further development of a mathematical model to predict the onset of iatrogenic anemia induced by repetitive phlebotomy in critical care patients. AACC Abstract Atlanta July 2011.
5. Chin AC, Lyon ME, Slotsve GA, Lyon AW. Mathematical estimation of iatrogenic anemia onset due to repetitive diagnostic blood loss in critical care patients. CSCC Vancouver, BC, June 2011. Clin Biochem 2011; 44: 1168-1169.
6. Drewniak M, Fenton TR, Lyon AW. What are the Best Fat Removal Methods in Making Low Fat Milk for Infants with Chylothorax? ASPEN Meeting Vancouver Jan 29, 2011
7. Straseski J, Lyon ME, Clarke W, Dubois JA, Lyon AW. Point-of-care whole blood creatinine analyses are influenced by
   matrix components of whole blood. 12th Asian-Pacific Congress of Clinical Biochemistry, Seoul, Korea. Oct 2010. p85 Congress Program.
8. Fenton TR, Lyon AW, Antunes A, Rose MS. Calcium phosphate, magnesium, and alkaline phophatase laboratory reference intervals for preterm infants.  Dietitians of Canada 13th Annual Conference,Montreal PQ, May 27-29, 2010. 2010:135.
9. Fenton TR, Lyon AW, Rose MS, Antunes A. Calcium phosphate, magnesium, and alkaline phophatase laboratory reference intervals for preterm infants.  Proceedings Canadian Nutrition Society,Edmonton AB, June 3-5, 2010. 2010:288
10. Lyon ME, Lyon AW. Predicted discrepancies between direct reading whole blood biosensors and central lab plasma methods: Predicting and avoiding medical error. AACC Point of Care Testing Conference, Boston, Sept 2010.
11. Lyon ME, Dubois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose and ascorbate. AACC Point of Care Testing Conference, Boston, Sept 2010.
12. Lyon AW. Updated case studies on recognition and assessment of assay interference.[Roundtable Presentation]. Canadian Society of Clinical Chemists Annual Meeting, Saskatoon, SK, June 13-16. 2010.
13. Gracie SK, Tough SC, Lyon AW, Pennell CE, Dolan SM, Lye SJ, Bocking AD, Olson DM. All our babies prediction of preterm birth study: A transdisciplinary transcriptomic approach to predict preterm birth. 18th Annual Western Perinatal Research Meeting, Banff, AB. Feb. 2010.
14. Pollak PT, Lyon AW, Verjee ZH. Rapid resolution of ripseridone induced QT prolongation following overdose - no evidence for delayed elimination of supratherapeutic dosing. Can J Cardiol 2009; 25 (Suppl B): 686.
15. Pollak PT, Lyon AW, Verjee ZH. Risperidone induced QT prolongation following overdose correlates with serum drug concentration and resolves rapidly with no evidence of altered pharmacokinetics. Clin Pharmacol Ther 2010; 87 (suppl 1): S41.
16. Lyon ME, Gray d, Dubois JA, Baskin LB, Lyon AW. Impact of Patient Hematocrit on Glucose Meter Performance. Diabetes Technology Conference, San Fransisco. Oct 2009.
17. Cembrowski GS, Tran DV, Lyon AW, Tandem Roche Hitachi 917 and Tandem Beckman LX-20 operated in two tertiary care hospitals exhibit comparable total patient-based imprecisions. Clin Chem 2009; 55: A105.
18. Khan, Faisal; Ueno-Yamanouchi, Aito; Serushago, Bazir; Bowen, Tom; Lyon, Andrew W; Lu, Cathy; Storek J. Basophil activation test compared to skin prick test and fluorescent enzymoimmunoassay for aeroallergen-specific IgE. Clin Immunol: 131 (Supp. 1), 2009; S145.
19. Fenton TR, Hanley DA, Eliasziw M Lyon AW. Tough S. The Association of Urine Measures of Diet-derived Acid Excretion with Bone Loss and Fractures: CaMOS Study. J Bone Min Res 23: S312-S312 Suppl. S 2008.
20. Fenton TR, Hanley DA, Eliasziw M Lyon AW. Tough S. Osteoporosis and the Acid-ash Hypothesis: Evidence Based on Bradford Hill's Criteria for Causality. J Bone Min Res 23: S196-S196 Suppl. S 2008.
21. Wesenberg JC, Higgins TN, Cembrowski GS, Tran DV, Lyon AW. A tale of HbA1c utilization in 4 Alberta cities. Clin Biochem 2008; 41: 1286.
22. Tran, DV; Lyon, AW; Higgins, TN, et al. Patient-derived long-term total analytic performance of Roche Integra 700, Roche Integra 400 and Dade Dimension RxL HbA1c immunoassays approach HPLC
    CLINICAL CHEMISTRY 54(6): A120-A120, 2008.
23. Dias, VC; Lyon, AW Correction for ethanol compromises the sensitivity of the osmolar gap to predict the presence of toxic alcohols: An observational study. CLINICAL BIOCHEMISTRY 41: 191-191: 2008.
24. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Savue R, MEC Study Team. Under what conditions would mothers consent to alcohol and drug screening of their newborns? Adv. Neonatal Care. 7(1): 50-51.2007
25. Zielke S, Ho NM, Lyon A, Abrahams Z, Warnica JW, Isaacs D. Adverse cardiac events and resource utilization in emergency department patients with symptoms of congestive heart failure and a low B-type natriuretic peptide (BNP) level: A prospective case series. Can J Cardiol 23: 193C Suppl C. 2007.
26. Flo NM, Zielke S, Smith H, Lyon A, Warnica JW, Isaacs DL. Comparison of the accuracy of BNP, NT-proBNP and emergency physicians in the diagnosis of heart failure in patients presenting with shortness of breath. Can J Cardiol 23: 193C, Suppl C. 2007.
    
27. Budd C, Krause RD, Lyon AW, Lyon ME. To acidify or not to acidify (urine): That is the question!. Clin Biochem 39(11): 1105. 2006
28. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Mitchell I, Sauve R. Under what conditions would mothers consent to alcohol and drug screening of their newborns? E-Pediatric Academic Society 2006;59:3571.314
29. Hicks M, Tough S, Lyon A, Premji S, Benzies K, Mitchell I, Sauve R. Alcohol and drug screening of newborns: conditions for maternal consent. Clinical and Investigative Medicine 2006;29(4):270.
30. Andrew W. Lyon, Janice James, Christine Lemaire, Bruce Culleton. Accurate laboratory results and reduction in labor using a multiple aliquot method to assess peritoneal dialysis adequacy in patients receiving CAPD Western Canadian Peritoneal Dialysis Days. Calgary, AB. Sept. 2004.
31. Antunes M, Fenton T, Lyon AW. Gestational-age specific reference ranges for markers of bone metabolism and renal function derived from umbilical cord blood Pediatric Research 55; 385A-385A 2189 Part 2 Suppl. S, APR 2004
32. Lyon, M.E., Hooper, T.A., Holden, T., Anderson, I., Lyon, A.W., and Wainer, S. Accuracy of the bilichek transutaneous bilirubinometer for the detection of neonatal hyperbilirubinemia using Canadian pediatric society diagnostic guidelines.Canadian Society of Clinical Chemists Annual Meeting, London, ON. June 2004.
33. Allegro, D.R., Stephenson, M.L., Nicholaichuk, S., Lyon, A.W., Church, D.L. and Lyon, M.E. Evaluation of the Bayer Clinitek 500 and the Multistix 8 SG dipstick to predict microscopic red blood cells in urine sediment. Canadian Society of Clinical Chemists Annual Meeting, London, ON. June 2004.
34. Martha E. Lyon, Andrew W. Lyon, Cheri Nijssen-Jordan, Charles M. Coleman. Can Chemistry and Hematology Laboratories Use a Common Blood Specimen? Genesis of Clinical Laboratory Integration 20th International Symposium on Critical Care and Point-fo-Care TEsting. Wurzburg, Germany, June 2004.
35. Lyon ME, Ball CL, Montgomery MD, Lyon AW. Diagnostic accuracy of sweat chloride and sweat sodium in the detection of cystic fibrosis compared to CFTR mutation analysis: A retrospective pediatric study. IX International Congress on Pediatric Laboratory Medicine, International Association of Pediatric Laboratory Medicine. Sept. 2003. Rome, Italy.
36. Vroegindewye A, Dalgleish S, Benzies K, Snozyk S, Lyon AW. Analytical evaluation of point-of-care glucose testing devices for use in neonatal intensive care. Clin Biochem.2003; 36: 487.
37. Lyon AW, Whitley C, Eintracht SL. Analytical evaluation of a novel serum lithium method in a rapid response laboratory. Clin Biochem 2003; 36: 493.
38. Simon V, Wells J, Yong VW, Herman RJ, Lyon AW. Microanalysis of serum minocycline by high performance liquid chromatography: applications to murine and human pharmacokinetic studies. Clin Biochem 2003; 36: 493
39. Simon V, Tough S, Johnston DW, Pollard J, Lyon A.W. (2002). Gas chromatography-mass spectrometry method for simultaneous determination of nicotine and cotinine in fetal and maternal plasma and urine from pregnant smokers using transdermal nicotine replacement therapy. Clin. Biochem. 35: 165
40. Haydon,CM, Tesanovic M, Lyon, AW. (2002) Multi-component diode array second-derivative spectrophotometric deter-mination of urine coproprophyrin and uroporphyrin. Clin. Biochem 35: 155
41. Lyon AW, Lyon ME (2002) Do we ever take too much blood? A mathematical model of iatrogenic anemia that indicates the influence of repetitive diagnostic phlebotomy on adult critical care patients. Clin. Biochem. 35: 163
42. Winfield S, Lyon AW (2002) Development of custom amniotic fluid bilirubin Liley reports with gestational-age specific reference ranges and percentage Liley zone 2 intervals to aid evaluation of Rh disease in utero. Clin. Biochem. 35: 151.
43. Kamencic H, Griebel RW, Lyon AW, Paterson PG, Matshes E and BHJ Juurlink, Promoting glutathione synthesis following spinal cord trauma decreases secondary damage and promotes retention of function. 7th Annual Life Sciences Research Day, January/2000, Saskatoon.
44. Kamencic H, Lyon AW, Griebel, RW Matshes, EW, Kelly M, Paterson PG, BHJ Juurlink (2000). The pro- cysteine compound L-2-oxothiazolidine-4-carboxylate promotes retention of function following spinal cord trauma. Restorative Neurology and Neuroscience 16 (3,4) p287.
45. Kamencic H, A.W.Lyon, P.G.Paterson, R.W.Griebel and B.H.J.Juurlink, There is rapid onset of oxidative stress following compression-induced spinal cord injury, Soc. Neurosci. Abstr., 25, 1329 (1999)
46. Kamencic H, Lyon AW, Paterson PG, Griebel RW, BHJ Juurlink. Oxidative stress following spinal trauma can be ameliorated by procisteine compounds, The Seventeenth Annual National Neurotrauma Society Symposium, J Neurotrauma, 1999 16 (10) p.975
47. Kamencic H, A.W.Lyon, P.G.Paterson, R.W.Griebel and B.H.J.Juurlink, Traumatic spinal cord injury results in rapid onset of oxidative stress, 6th Annual Life Sciences Research Day, Saskatoon, 1999.
48. Lyon ME, Rutledge Harding S, Lyon AW. 1999 Use of selective thrombin inhibitor, D-phenylalanyl-L-Prolyl-L-arginine-chloromethylketone (PPACK) with a factor Xa inhibitor, 1, 5-Dansyl-L-glutamyl-L-glycyl-L-Arginine chloromethylketone (GGACK) for the preservation of blood cells and platelets ex vivo. Clin Biochem. 32: 295.
49. Zhang Z., Lyon AW, Paterson PG. 1999 The influence of dietary protein of brain glutathione concentration in relation to stroke. The 5th Altschul Symposium and 4th WHO Summer School, Saskatoon, SK. August.
50. Kamencic H, Lyon AW, Paterson PG, Juurlink BHJ. 1998 Traumatic spinal cord injury results in rapid onset of oxidative stress. Society for Neuroscience Annual Meeting, Los Angeles, CA. Soc. Neurosci 24: 1166.
51. Kamencic H, Lyon AW, Juurlink BHJ. 1998. Comparison of two methods to determine reduced-glutathione (GSH) content of rat liver. 5th Internet World Congress for Biomedical Sciences. (www.mcmaster.ca/inabis98)
52. Paterson PG, Juurlink BHJ, Lyon AW. 1998. Regulation of brain glutathione concentration by dietary sulfur amino acids. Society for Neuroscience Annual Meeting, Los Angeles, CA. Soc. Neurosci 24: 1167.
53. Lyon AW, Meinert P, Bruce GA, Laxdal VA, Salkie ML. 1998. The influence of methodology on the diagnosis of congenital analbuminemia. Clin Biochem. 31:296.
54. Katrusiak AE, Shoker AS, Lyon AW. A sensitive uv-hplc method for the determination of sulfhydryl and disulfide amino acids in human plasma. Clin. Biochem. 1997; 30: 375.
55. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. Use of thrombin inhibitors ex vivo allows critical care clinical chemistry and hematology testing on common specimens. in Significant Advances in Critical Care Testing, ed. M. Muller, W. List, M.J.McQueen, Springer Verlag (Heidelberg,1997)pp 223-4.
56. Lyon AW, Rutledge Harding S, Drobot D, Lyon ME. Evaluation of Concord calcium neutralized dry lithium heparin Pro-Vent blood gas syringes for determination of blood gases, electrolytes and ionized calcium. Clinical Chemistry 1996; 42: S279.
57. Drobot D, Rutledge Harding S, Lyon AW, Lyon ME. Use of a thrombin inhibitor,
    D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) with a factor Xa inhibitor, 1,5-dansyl-L-glutamyl-L-glycyl-L-arginine chloromethylketone (GGACK) for anticoagulation of clinicalchemistry specimens. Clinical Chemistry 1996; 42: S278.
58. Hofgartner WT, Duran G, Lyon AW, Raisys VA. 1995. Quantitative determination of thymidine triphosphate by reversed phase high performance liquid chromatography with bioluminescent detection. American Journal Clinical
    Pathology: 104: 217.
59. Lyon ME, Fine JS, Henderson PJ, Lyon AW. 1995. Evaluation of a novel anticoagulant, D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK) on blood gas, electrolyte and ionized calcium analyses. Clinical Biochemistry 28:338
60. Lyon AW, Lyon ME. 1995. Comparison of anticoagulant bias with aspartate transaminase (AST), amylase, creatine kinase (CK) and creatine kinase MB (CK-MB) analyses on the kodak ektachem 700 analyzer. Clinical Biochemistry 28:338-339.
61. Lyon AW, Duran G, Raisys VA. 1994. Determination of thalidomide in human plasma: Methodological design for clinical trials. Clinical Biochemistry 27:209
62. Pereira CM, Lyon AW, Unadkat JD, Raisys VA. 1993. Simultaneous determination of dideoxyinosine (DDI) and zidovudine (ZDV) in human plasma by HPLC. Clinical Chemistry 39:1231
63. Lyon AW, Greenway DC, Hindmarsh JT. 1993. Strategies to promote cost-effective biochemistry test ordering. Clinical Biochemistry 26:132
64. Hindmarsh JT, Greenway DC, Lyon AW. 1993. Techniques to improve biochemistry test ordering practices. Clinical Investigative Medicine, Volume 16, Supplement:B86
65. Lyon ME, Lyon AW, Toivola B. 1993. Concordance of clinical thyroid status with thyroid function tests: A quality assurance program. American Journal Clinical Pathology 100:174
66. Lyon AW, Anastassiades T, Kisilevsky R. 1991. In vivo analysis of murine splenic glycosaminoglycan biosynthesis and sulphate metabolism during acute inflammation. Clinical Chemistry 37:1069
67. Dow K, Riopelle R, Bols M, Ison ER, Szarek WA, Lyon AW, Kisilevsky R. 1990. Effects of a novel carbohydrate, 4-deoxy-L-threo-pentose on neural cell proteoglycan synthesis and function. Neurobiol of Aging 11(3): 307. 1990.
68. Lyon AW, Kisilevsky R. 1988. Analysis of hepatic ribosomes, ribosomal subunits and initiation factor two (eIF-2) during acute ethionine intoxication of the rat. FASEB Journal 2:A777
69. Lyon AW, Kisilevsky R. 1985. Regulation of hepatic protein synthesis: The role of insulin and glucagon during acute ethionine intoxication. Laboratory Investigation 52:40A
    
    Technical Reports
    
    Unadkat J, Raisys V, Lyon AW, Collier AC. 1994. Intracellular pharmcokinetics of zidovudine triphosphate after single and multiple dose administration of zidovudine - A substudy to ACTG 276. A.C. Concept Sheet October . Aids Clinical Trial Group, NIH , Rockville, MD, U.S.A.

Videos, Media and Electronic Publications

Preterm Birth and Healthy Outcomes Team: AIHS Video. Andrew Lyon PhD PreHOT [Video online]

The International Federation of Clinical Chemistry and Laboratory Medicine Website. www.ifcc.org. (Sept 2009 - present).

The Department of Pathology and Laboratory Medicine, University of Calgary. www.ucalgary.ca/UofC/faculties/medicine/PATH/ (2000-2002).

The Canadian Academy of Clinical Biochemistry Website www.cscc.ca/academy/ (1999-2001)

The Canadian Society of Clinical Chemists Website: www.cscc.ca (1996-2001)

Video Interview: Canadian Society of Clinical Chemist's 50th Anniversary Founding Member Interviews ( 5 DVD set, David Robert Productions 2006). Interview of Dr. Allan Trew by Andrew Lyon, DVD #5, ( 28 min).

The Department of Pathology University of SaskatchewanWebsite: www.usask.ca/medicine/pathology. (1995-2000).

Invited Lectures

Lyon AW. Laboratory evaluation of the poisoned patient. 25th Aniverary of the Poison and Drug Information Service, Calgary. University of Calgary, Nov 5th, 2011.

Lyon AW. A brief history of analbuminemia. Special IFCC CPD symposia, Hospital for Sick Children, Toronto. Sept 2011.

Lyon AW. Webinairs, streaming media, blogs and other e-communications & clinical laboratories. IFCC – WorldLab – EuroMedLab Berlin 2011, 15-19 May 2011. Clin Chem Lab Med 2011; 49, Special Suppl, p S26.

Lyon AW. Are Glucose Meters Accurate and Precise Enough to Meet Clinical Needs?[ CSCC National Teleconference - Roundtable, Dec. 10, 2010].

Lyon AW. Webinars, Streaming Media, Blogs and Other e-communications: Beyond Email. IFCC Symposia on Distance Learning. 12th Asian-Pacific Congress on Clinical Biochemistry, Seoul, Korea. Kor. J. Lab Med 2010; 30 suppl 2: S295.

Fariba Aghahafari, James A Dickinson, Rajeswari Aghoram, Andrew W Lyon. Should we measure vitamin D on all our patients? Family Medicine Forum 2009, Calgary AB, Oct 30th, 2009. College of Family Physicians of Canada.

Lyon AW, Life without Albumin: A brief history of analbuminemia.Univ. Utah, Dept. Pathology and Laboratory Medicine, Aug 31, 2009.

Lyon AW, Life Without Albumin, Swedish Society of Clinical Chemists, Grand Hotel Boras, Boras, Sweden, May 2007

Lyon AW, Pasieka J, The Paradigm Shift in Parathyroid Surgery, The Banff Pathology Course (Univ. Alberta, Univ. Calgary), Rimrock Resort Hotel, Banff, Sep 2006

Lyon AW Serum Tumor Markers: Past, Present and Future. Chemistry CE Lecture, CHR Hospitals and DSC Nov 2004

Lyon AW Serum Tumor Markers: Past, Present and Future. Department of Pathology and Laboratory Medicine Rounds. CHR Hospitals Oct 2004

Lyon AW A Prairie Encounter with Analbuminemia. Alberta College of Medical Laboratory Technologists, Jasper AB. Sept 2004

Lyon AW A Review of Recent International Guidelines on Reporting Monoclonal Gammopathies. Somagen Diagnostics Inc. Jasper, AB Sept 2004

Lyon AW Use of the Internet for Pathology and Laboratory Medicine: An update. Alberta College of Medical Laboratory Technologists. Jasper, AB Sept 2004

Lyon AW A Prairie Encounter with Analbuminemia. MDS Laboratories Medical Scientific teleconference, Canada – USA. May 2004

Lyon AW Case Studies of Abnormal Protein Electrophoresis Patterns. Workshop contributor. Somagen Diagnostics Inc. Calgary, Alberta. Oct. 2003

Lyon AW Sodium: The Spice of Life. Alberta Ortho Clinical Diagnostics Users Group. Canmore, Alberta Sept. 2003

Lyon AW The Pathophysiology of Jaundice. Alberta Society of Medical Laboratory Technologists. Annual Meeting. Canmore, Alberta. Sept. 2003

Lyon AW, Lyon ME. Does Diagnostic Blood Loss Contribute to the Risk of Transfusion in Adult Critical Care Patients? Critical Care Advisory Board – Ortho Biotech, Calgary AB Nov14, 2002

Scott R, Lyon AW. Lab Medicine and Pathology Online in 2002 – A Hands-On Interactive Tour. Canadian Laboratory Medicine Congress, May 21, 2002

Lyon AW. 1998. Neuropsychiatric Research Unit. Department of Psychiatry. College of Medicine, University of Saskatchewan.

Yatscoff R, Lyon AW, McQueen M. 1997.Forum on Laboratory Utilization Professional Affairs Division. Annual Meeting of the Canadian Society of Clinical Chemists. Halifax, NS.

Lyon AW. 1995, 1996. Department of Biochemistry, University of Saskatchewan.

Lyon AW. 1995, 1996. College of Pharmacy and Nutrition. University of Saskatchewan.

Lyon AW. 1995. Measurement of ZDV triphosphate by an HPLC/bioluminescence assay, at: Measuring zidovudine phosphorylation in patients: Methods and clinical relevance. May 19-21. Cincinnati, OH.

Lyon AW. 1995. Zidovudine triphosphate measurement with an HPLC/Bioluminescence method. Intracellular Nucleoside Workshop. AIDS Clinical Trial Group (Core pharmacology) Meeting. June 25-27. Stanford University. Palo Alto, CA.

Lyon AW. 1995. Effects of thrombin inhibitors on laboratory tests. Saskatchewan Society of Clinical Chemists. Spring Meeting. May 26. Regina, SK.